Zubsolv Tablet, Orally Disintegrating
Product Images NDC 82111-203

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Zubsolv (NDC 82111-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Edenbridge Pharmaceuticals Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (0 7mg Carton)

1 (0 7mg Carton)
This document provides instructions for pharmacists on the proper dispensing and administration of ZUBSOLV sublingual tablets containing buprenorphine and naloxone. Important guidelines include how to accurately counsel patients on the correct usage, storage conditions, and precautions to avoid potential risks such as respiratory depression especially in children. The tablets should be placed under the tongue until fully dissolved and should not be cut, crushed, or swallowed. For detailed information, refer to the enclosed ZUBSOLV Medication Guide.*
FDA Label Image

1 (1 4mg Carton)

1 (1 4mg Carton)
This text provides information about Zubsolv, which is a medication containing buprenorphine and naloxone in sublingual tablet form. It includes instructions for usage, storage, and safety precautions, such as keeping it out of reach of children due to the risk of respiratory depression if accidentally ingested. The text emphasizes the importance of following the prescribed dosage and administration method, as well as the availability of a Medication Guide for further details. Additional guidance on how to take the tablets correctly is also provided, emphasizing the importance of allowing the tablet to dissolve completely under the tongue.*
FDA Label Image

1 (11 4mg Carton)

1 (11 4mg Carton)
This is a description of Zubsolv sublingual tablets, a medication containing buprenorphine and naloxone used to treat opioid dependence. The usage instructions include placing the tablet under the tongue to dissolve and not cutting, crushing, breaking, chewing, or swallowing it. It is important to follow the dosage prescribed by a doctor and to keep the medication out of reach of children to prevent accidental ingestion, as it can cause severe respiratory depression. For more safety information, the enclosed Zubsolv Medication Guide should be referred to, and immediate medical attention is required if a child accidentally takes the medication.*
FDA Label Image

1 (2 9mg Carton)

1 (2 9mg Carton)
This is a medication guide for Zubsolv, a sublingual tablet used to treat opioid dependence. The guide provides instructions on how to take the tablet, such as placing it under the tongue and letting it dissolve completely. It emphasizes not cutting, crushing, breaking, chewing, or swallowing the tablet. The guide also highlights the importance of storing Zubsolv safely, away from children, as it can cause severe respiratory depression if accidentally taken by them. Additionally, it urges immediate medical attention for children who ingest the medication and provides contact information for further inquiries or emergencies.*
FDA Label Image

1 (5 7mg Carton)

1 (5 7mg Carton)
This text provides detailed instructions and information about Zubsolv, which is a medication containing buprenorphine and naloxone in sublingual tablet form. It includes guidance on how to take the tablets, warnings about the potential risks, dosage information, and storage instructions. Additionally, the text advises on counseling patients and providing a Medication Guide to each patient. For further questions about Zubsolv, a contact number is provided for assistance.*
FDA Label Image

1 (8 6mg Carton)

1 (8 6mg Carton)
This is a description about a medication called Zubsolv. Zubsolv is a sublingual tablet that contains buprenorphine and naloxone. It comes in a flavor with Menthol. The tablets are diamond-shaped and need to be placed under the tongue to dissolve completely. Dosages higher than 1 tablet require placing all tablets in different positions under the tongue simultaneously. Unused tablets should be flushed immediately. It is crucial to keep Zubsolv out of sight and reach of children as it can cause severe respiratory depression if accidentally consumed. Patients should follow the instructions provided by their doctor and pharmacist, and it is recommended to consult the enclosed Medication Guide for important safety information. For inquiries about Zubsolv, individuals can contact 1-888-ZUBSOLV (1-888-962-7658).*
FDA Label Image

1 (Buprenorphine)

FDA Label Image

1 (Figure A)

FDA Label Image

1 (Figure B)

FDA Label Image

1 (Figure C)

FDA Label Image

1 (Figures D E F)

FDA Label Image

1 (Naloxone)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.